How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?

How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?

Alzheimer–Perusini’s (AD) disease represents the most spread dementia around the world and constitutes a serious problem for public health. It was first described by the two physicians from whom it took its name. Nowadays, we have extensively expanded our knowledge about this disease. Starting from...

Full description

Bibliographic Details
Main Authors:	Luigi Donato, Domenico Mordà, Concetta Scimone, Simona Alibrandi, Rosalia D’Angelo, Antonina Sidoti
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Biomedicines
Subjects:	atypical AD forms microglia genetics amyloid plaques neurofibrillary tangles
Online Access:	https://www.mdpi.com/2227-9059/11/7/2035

Similar Items

Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer’s disease
by: Clara Muñoz-Castro, et al.
Published: (2022-02-01)

Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01)

The neuropathological diagnosis of Alzheimer’s disease
by: Michael A. DeTure, et al.
Published: (2019-08-01)

Aducanumab: A new hope in Alzheimer's disease
by: Rouchan Ali, et al.
Published: (2022-09-01)

Bridging Retinal and Cerebral Neurodegeneration: A Focus on Crosslinks between Alzheimer–Perusini’s Disease and Retinal Dystrophies
by: Luigi Donato, et al.
Published: (2023-12-01)

Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer’s disease
by: Mehrdad Jahanshahi, et al.
Published: (2020-01-01)

Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
by: Md. Sahab Uddin, et al.
Published: (2019-09-01)

Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
by: Eliasz Engelhardt, et al.
Published: (2024-12-01)

Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
by: Ali Azargoonjahromi, et al.
Published: (2024-03-01)

Evaluating p-tau217 and p-tau231 as Biomarkers for Early Diagnosis and Differentiation of Alzheimer’s Disease: A Narrative Review
by: Dorian Julian Jarek, et al.
Published: (2024-04-01)

Selective In Vitro and Ex Vivo Staining of Brain Neurofibrillary Tangles and Amyloid Plaques by Novel Ethylene Ethynylene-Based Optical Sensors
by: Florencia A. Monge, et al.
Published: (2023-01-01)

Amyloid beta 1-42 and phoshorylated tau threonin 231 in brains of aged cynomolgus monkeys (Macaca fascicularis)
by: Huda Shalahudin Darusman, et al.
Published: (2014-11-01)

Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)

The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
by: Julius Mulumba, et al.
Published: (2025-02-01)

Mapping the Spatial Distribution of Fibrillar Polymorphs in Human Brain Tissue
by: Abdullah Al Bashit, et al.
Published: (2022-06-01)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2020-02-01)

PICALM and Alzheimer’s Disease: An Update and Perspectives
by: Kunie Ando, et al.
Published: (2022-12-01)

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches
by: Ayomide Victor Atoki, et al.
Published: (2023-09-01)

Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer’s disease pathology in mice
by: Christiana Bjorkli, et al.
Published: (2022-08-01)

Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease
by: Ellis Patrick, et al.
Published: (2017-07-01)

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
by: Jie Liu, et al.
Published: (2019-08-01)

MicroRNAs in Alzheimer’s Disease
by: Mengli Wang, et al.
Published: (2019-03-01)

Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
by: Minghui Wang, et al.
Published: (2023-03-01)

Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species
by: Dayan B. Goodenowe, et al.
Published: (2022-08-01)

Clinical Relevance of [<sup>18</sup>F]Florbetaben and [<sup>18</sup>F]FDG PET/CT Imaging on the Management of Patients with Dementia
by: Damiano Librizzi, et al.
Published: (2021-02-01)

Modeling Traumatic Brain Injury in Human Cerebral Organoids
by: Santiago Ramirez, et al.
Published: (2021-10-01)

Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease
by: Yi-Jun Xu, et al.
Published: (2022-05-01)

A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases
by: Selma M. Soyal, et al.
Published: (2020-08-01)

From Small Peptides to Large Proteins against Alzheimer’sDisease
by: Pasquale Picone, et al.
Published: (2022-09-01)

Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?
by: Tsu-Kung Lin, et al.
Published: (2024-11-01)

Hippocampal Changes in Down’s Syndrome
by: J Gordon Millichap
Published: (1995-05-01)

Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer’s disease pathology: a population-based autopsy study in an admixed sample
by: Regina Silva Paradela, et al.
Published: (2023-12-01)

Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
by: Evelin L. Schaeffer, et al.
Published: (2011-01-01)

Anticholinesterase activity of Areca Catechu: In Vitro and in silico green synthesis approach in search for therapeutic agents against Alzheimer’s disease
by: Sushma Pradeep, et al.
Published: (2022-11-01)

Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
by: Md. Sahab Uddin, et al.
Published: (2020-03-01)

Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms
by: Sai Sreenivasamurthy, et al.
Published: (2023-03-01)

Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
by: Zhikun Shi, et al.
Published: (2022-11-01)

Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Samo Ribarič
Published: (2018-01-01)

Multifaceted neuroprotective approach of Trolox in Alzheimer's disease mouse model: targeting Aβ pathology, neuroinflammation, oxidative stress, and synaptic dysfunction
by: Muhammad Tahir, et al.
Published: (2024-09-01)

A peephole into the brain: Neuropathological features of Alzheimer’s Disease revealed by in vivo two-photon imaging
by: Sabine eLiebscher, et al.
Published: (2012-04-01)